These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 201047)

  • 1. Effects of dibutyryl cyclic-AMP on cardiac output and myocardial contractility in dogs.
    Okuaki A
    Tohoku J Exp Med; 1977 Oct; 123(2):139-45. PubMed ID: 201047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dibutyryl cyclic AMP on myocardial performance in vivo.
    Cutilletta AF; Lin CY; Thilenius OG; Arcilla RA
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():251-9. PubMed ID: 4377598
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dibutyryl cyclic AMP on sinus rate and atrial contractile force in the isolated atrium of the dog.
    Chiba S
    Tohoku J Exp Med; 1975 Jan; 115(1):81-4. PubMed ID: 165587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and metabolic effects of dibutyryl cyclic AMP in the intact dog heart and the isolated perfused rat heart.
    Dhalla NS; Chernecki W; Gandhi SS; McNamara DB; Naimark A
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():233-50. PubMed ID: 4377597
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular effects of dibutyryl cyclic AMP in the intact dog heart and the isolated cross-perfused right atrium.
    Furukawa Y; Ogiwara Y; Saegusa K; Takeda M; Chiba S
    Jpn Heart J; 1988 Jul; 29(4):465-73. PubMed ID: 2846907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of dibutyryl cyclic AMP and milrinone under right heart bypass in anesthetized dogs.
    Kondo M; Washizu M; Kinoshita G; Matsukura Y; Kobayashi K; Misaka K; Orima H; Washizu T; Motoyoshi S
    J Vet Med Sci; 1994 Oct; 56(5):923-8. PubMed ID: 7865595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.
    Ogiwara Y; Furukawa Y; Saegusa K; Takeda M; Chiba S
    Arch Int Pharmacodyn Ther; 1988; 291():41-54. PubMed ID: 2835022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of BTB-cyclic AMP in anesthetized dogs.
    Imura K; Ogawa K; Ito T; Satake T
    Jpn Heart J; 1986 Sep; 27(5):741-7. PubMed ID: 3029452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dibutyryl cyclic-AMP on the cardiac output and organ blood flow of anesthetized dogs.
    Nozaki H; Okuaki A
    Fukushima J Med Sci; 1976; 23(3-4):39-44. PubMed ID: 206494
    [No Abstract]   [Full Text] [Related]  

  • 11. Responses to exogenous dibutyryl adenosine 3',5'-monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs.
    Nozaki H; Okuaki A
    Tohoku J Exp Med; 1975 Feb; 115(2):145-54. PubMed ID: 165589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive dromotropic effect of dibutyryl cyclic adenosine 3',5'-monophosphate on the atrioventricular node.
    Narimatsu A; Taira N
    Eur J Pharmacol; 1977 Mar; 42(1):71-8. PubMed ID: 191261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the diuretic action produced dibutyryl cyclic AMP in dogs.
    Saito H; Nishida H; Shudo I; Tawara K; Monma Y
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):391-4. PubMed ID: 169556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo.
    Kitayoshi T; Watanabe T; Shimamoto N
    Eur J Pharmacol; 1989 Aug; 166(3):519-22. PubMed ID: 2680523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclic AMP and dibutyryl cyclic AMP on the heart and coronary circulation.
    Imai S; Otorii T; Takeda K; Katano Y; Horii D
    Jpn J Pharmacol; 1974 Aug; 24(4):499-510. PubMed ID: 4376183
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):735-43. PubMed ID: 193168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3',5'-phosphate (SQ 80122).
    Evans DB; Parham CS; Schenck MT; Laffan RJ
    J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):307-19. PubMed ID: 184129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.